Compare Bank of America Corp (BAC) vs Sana Biotechnology Inc (SANA) Price & Performance

Bank of America CorpTrade

Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Bank of America Corp vs Sana Biotechnology Inc — how do they compare? Bank of America Corp trades at $61.68 (market cap $425.43B), while Sana Biotechnology Inc trades at $3.55 (market cap $994.89M). The key difference: Bank of America Corp is far larger — about 427.6× Sana Biotechnology Inc's market cap, and Bank of America Corp pays a 1.85% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.

	BAC	SANA
Market Cap	$425.43B	$994.89M
Volume	55,637,172	—
Sector	Financials	Health
52-Week High	$60.62	$5.92
52-Week Low	$44.92	$2.68
Dividend Yield	1.85%	—
Enterprise Value	—	$969.08M

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bank of America Corp

No Aura AI signal available yet.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.64, down 5.45% over 24 hours, with a bullish technical signal and strong analyst support (81.82% buy ratings). Recent news highlights clinical progress, including NEJM publications and conference presentations, but financials show significant losses with a net income of -$244.17M in 2025 and negative cash flows.

The outlook is mixed: strong scientific momentum and Wall Street optimism contrast with deep financial losses and high burn rate. Key risks include funding needs and clinical trial outcomes, while potential upside hinges on successful product development and partnerships.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BAC

Stock market not in a dot-com bubble, says Jim Cramer, citing lower valuations and strong earnings.CNBC · 19 hours agoBullish Bank of America to redeem $5.75B in notes on July 22, 2026, ending interest accrual.PRNewsWire · 21 hours agoNeutral Bank of America beats Q2 earnings with strong loan growth and rising net interest income.Seeking Alpha · 1 day agoBullish View details →

SANA

New England Journal of Medicine highlights long-term success of Sana's insulin cell therapy for type 1 diabetes without immunosuppressionGlobeNewsWire · 2 days agoBullish View details →

About Bank of America Corp

Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.